The Complex Disease Genetics group within the Data, AI and Genome Sciences (DAGS) Department at our Company is seeking an accomplished Associate Director /Associate Principal Data Scientist to advance our Cambridge-based research initiatives in complex disease genetics. We invite applications from highly motivated scientists with a doctoral degree (PhD or equivalent) in statistical genetics, genetic epidemiology, computational biology, biostatistics, or a related discipline. The ideal candidate will demonstrate a robust track record in research and publication, expertise in large-scale human genetics and multi-omics analyses, and a passion for translational research in drug discovery and precision medicine. As a member of the Precision Disease Genetics group, you will leverage advanced statistical genetics methodologies to analyze large-scale public and proprietary datasets, including population-based biobanks, deeply phenotyped patient cohorts, and family-based studies, which encompass genetic and genomic data linked with electronic health records, clinical, biomarker, imaging, and clinical laboratory data. Our Company has strategically invested in external partnerships and collaborative initiatives to accelerate innovation in drug discovery and development. The Complex Disease Genetics group is aiming to leverage these world-class resources, including FinnGen, the Alliance for Genomic Discovery, Our Future Health, UK Biobank Pharma Proteomics Project, Open Targets, and a range of other public and proprietary datasets, to advance our Company's drug development pipeline through cutting-edge human genetics research. Your research will directly inform our Company's drug development pipeline, supporting target identification and validation and the implementation of precision medicine strategies across therapeutic areas. You will have the opportunity to lead and shape collaborative research efforts, both internally and with external academic and industry partners, to drive innovation and maximize the translational impact of human genetics on drug development.